BOLD Competitors & Alternatives

Compare Boundless Bio, Inc. Common Stock with similar stocks in the same industry

Biotechnology

BOLD

Main Stock
$2.32
-2.52%
Tradestie Score
33
Market Cap
$27.53M
Analyst Upside
+72.4%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other Drug Design
Competitive Moat: None
Core Technology Stack: ecDNA targeting small molecules
Major Customers 2
oncology research institutions future hospital systems
Critical Suppliers 3
CROs CDMOs raw material suppliers
Direct Ecosystem Rivals 0
Sole-source / monopoly positioning in sub-sector.

Top Competitors

213 stocks in Biotechnology
Company Price Market Cap P/E Score Action
DERM Journey Medical Corporation Common Stock
$3.30
-7.04%
$190.75M - 39 Compare
FBRX Forte Biosciences, Inc. Common Stock
$76.99
+0.03%
$180.53M - 54 Compare
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$19.39
-2.27%
$154.27M - 38 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$6.58
-6.00%
$137.59M - 36 Compare
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

213 stocks in this industry